A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Iobenguane


Market Report -- In Play (WIRES)  -  May 10, 2007
MSN MoneyMolecular Insight Pharmaceuticals (MIPI) announces that it has initiated a two-stage, Phase 1/2 therapeutic clinical trial for Azedra (Ultratrace iobenguane

AnazaoHealth Teddy Bears are 'Making It Bearable For Kids™'  -  Mar 22, 2007
SocialFunds.comMIBG (metaiodobenzylguanidine) is a biotracer that is combined with radioactive iodine to form either 123I-iobenguane metaiodobenzylguanidine, I-123 MIBG,

DRAXIS Posts Record Earnings and Cash Flow for 2006  -  Feb 8, 2007
CNW Telbec (Communiqués de presse),In November 2006, DRAXIMAGE received approval from the US Food and Drug Administration (FDA) to run two clinical trials using radioactive Iobenguane I-131

Molecular Insight Pharmaceuticals, Inc. Acquires Malignant ...  -  18 Jan 2007
PipelineReview.com (press release),ZK-BA (Solazed(TM)) joins Azedra(TM) (Ultratrace(TM) iobenguane I 131) and Onalta(TM) (an yttrium-90 radiolabeled somatostatin peptide analog) in Molecular

DRAXIS Radiopharmaceutical Unit Approved To Run 2 Clinical Trials ...  -  Nov 23, 2006
Medical News Today (press release),...(TSX: DAX) (NASDAQ: DRAX) has been approved by the US Food and Drug Administration (FDA) to run two clinical trials using radioactive Iobenguane I-131 ...

DRAXIS Radiopharmaceutical Unit Approved to Run 2 Clinical Trials ...  -  Nov 22, 2006
CNW Telbec (Communiqués de presse),...(TSX: DAX) (NASDAQ: DRAX) has been approved by the US Food and Drug Administration (FDA) to run two clinical trials using radioactive Iobenguane I-131 ...


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional